Lenacapavir：如果游戏公平进行，它可能改变美洲艾滋病预防的游戏规则

IF 7 Q1 HEALTH CARE SCIENCES & SERVICES

Lancet Regional Health-Americas Pub Date : 2025-06-10 DOI:10.1016/j.lana.2025.101146

Valeria D. Cantos , Brenda Crabtree Ramírez , Colleen F. Kelley , Carlos del Rio , Beatriz Grinsztejn

{"title":"Lenacapavir：如果游戏公平进行，它可能改变美洲艾滋病预防的游戏规则","authors":"Valeria D. Cantos , Brenda Crabtree Ramírez , Colleen F. Kelley , Carlos del Rio , Beatriz Grinsztejn","doi":"10.1016/j.lana.2025.101146","DOIUrl":null,"url":null,"abstract":"<div><div>Lenacapavir, a first in class long-acting capsid inhibitor has near 100% efficacy in preventing HIV. As such, it has the potential to curb the rising HIV incidence in Latin America, a region with stark intra- and inter-country PrEP uptake disparities. In this viewpoint, we summarize the current efforts to scale up lenacapavir access globally and the necessary steps to include Latin America in these endeavours.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"47 ","pages":"Article 101146"},"PeriodicalIF":7.0000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lenacapavir: a potential game changer for HIV prevention in the Americas, if the game is played equitably\",\"authors\":\"Valeria D. Cantos , Brenda Crabtree Ramírez , Colleen F. Kelley , Carlos del Rio , Beatriz Grinsztejn\",\"doi\":\"10.1016/j.lana.2025.101146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Lenacapavir, a first in class long-acting capsid inhibitor has near 100% efficacy in preventing HIV. As such, it has the potential to curb the rising HIV incidence in Latin America, a region with stark intra- and inter-country PrEP uptake disparities. In this viewpoint, we summarize the current efforts to scale up lenacapavir access globally and the necessary steps to include Latin America in these endeavours.</div></div>\",\"PeriodicalId\":29783,\"journal\":{\"name\":\"Lancet Regional Health-Americas\",\"volume\":\"47 \",\"pages\":\"Article 101146\"},\"PeriodicalIF\":7.0000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Regional Health-Americas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667193X25001565\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Americas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667193X25001565","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

摘要

Lenacapavir是一类首个长效衣壳抑制剂，其预防HIV的功效接近100%。因此，它有可能遏制拉丁美洲不断上升的艾滋病毒发病率，该地区在国家内部和国家之间的PrEP使用差异明显。在这一观点下，我们总结了目前在全球范围内扩大lenacapavir获取的努力，以及将拉丁美洲纳入这些努力的必要步骤。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Lenacapavir: a potential game changer for HIV prevention in the Americas, if the game is played equitably

Lenacapavir, a first in class long-acting capsid inhibitor has near 100% efficacy in preventing HIV. As such, it has the potential to curb the rising HIV incidence in Latin America, a region with stark intra- and inter-country PrEP uptake disparities. In this viewpoint, we summarize the current efforts to scale up lenacapavir access globally and the necessary steps to include Latin America in these endeavours.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lancet Regional Health-Americas Multiple-

CiteScore

8.00

自引率

0.00%

发文量

期刊介绍： The Lancet Regional Health – Americas, an open-access journal, contributes to The Lancet's global initiative by focusing on health-care quality and access in the Americas. It aims to advance clinical practice and health policy in the region, promoting better health outcomes. The journal publishes high-quality original research advocating change or shedding light on clinical practice and health policy. It welcomes submissions on various regional health topics, including infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, emergency care, health policy, and health equity.